About Miltenyi Biotec
Miltenyi Biotec is a company based in Bergisch Gladbach (Germany) founded in 1989 by Stefan Miltenyi. The company has 585 employees as of December 31, 2020. Miltenyi Biotec has completed 3 acquisitions, including LaVision BioTec, Lentigen and lino Biotech. Miltenyi Biotec operates in a competitive market with competitors including Abcam, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter Bergisch Gladbach, Germany
- Employees 585 as on 31 Dec, 2020
- Founders Stefan Miltenyi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$304.41 K (USD), Grant
Mar 01, 2021
-
Investors
HHS
& 1 more
-
Employee Count
585
as on Dec 31, 2020
-
Investments & Acquisitions
LaVision BioTec
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Miltenyi Biotec
Investors in Miltenyi Biotec
Miltenyi Biotec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Miltenyi Biotec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Miltenyi Biotec
Miltenyi Biotec has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include LaVision BioTec, Lentigen and lino Biotech.
Investment portfolio details for Miltenyi Biotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Molecular interactions in biological samples are measured via focal molography.
|
Locked | Locked | 2020 | Locked | |
|
Lentiviral vectors are developed for pre-clinical and clinical applications.
|
Locked | Locked | 2004 | Locked | |
|
Microscopes for cell analysis and preclinical imaging are developed.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Miltenyi Biotec
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Miltenyi Biotec
Detailed financials for Miltenyi Biotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Miltenyi Biotec Comparisons
Peer comparison for Miltenyi Biotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Miltenyi Biotec
Miltenyi Biotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of Miltenyi Biotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Miltenyi Biotec
Complete news archive for Miltenyi Biotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Miltenyi Biotec
Miltenyi Biotec was founded in 1989 and raised its 1st funding round 21 years after it was founded.
Miltenyi Biotec is headquartered in Bergisch Gladbach, Germany. It is registered at Bergisch Gladbach, North Rhine-westphalia, Germany.
Boris Stoffel is the current CEO of Miltenyi Biotec.
As of Dec 31, 2020, the latest employee count at Miltenyi Biotec is 585.
Founded in 1989 and headquartered in Bergisch Gladbach, Germany, the company operates in the biomedical research and cellular therapy sector. Products are provided for cell isolation, flow cytometry, sample preparation, cell culture, molecular analysis, clinical applications, and imaging. Expertise is maintained in immunology, stem cell biology, neuroscience, cancer research, hematology, graft engineering, and apheresis.
Miltenyi Biotec's top competitors include Abcam, Sutro Biopharma and Avidity Biosciences.
Miltenyi Biotec has made 3 acquisitions, including LaVision BioTec, Lentigen, and lino Biotech.
Miltenyi Biotec has 2 investors. Key investors include HHS, and European Union.